Alicia Garrido

Dr. Alicia Garrido is a neurologist at the Hospital Clínico de Barcelona and serves as the deputy director of the Parkinson's Progression Markers Initiative (PPMI). She is actively involved in redefining the approach to Parkinson's research, advocating for lowering the age threshold for clinical trials from 60 to 40 years to better understand the disease's early onset. Her work focuses on the non-motor symptoms in Parkinson's patients, particularly within the Hispanic and Latino communities, and aims to enhance early detection and preventive strategies in the field.